According to that, several randomized controlled clinical trials (Table 5) and meta-analyses have investigated the effect of lactoferrin administration on respiratory tract infections in both adult and pediatric populations, showing its overall effectiveness in reducing infection risk and improving clinical recovery, especially in infants and children [83,147,148]. The gene discussed is LTF; the disease is infection.